Brain function improving agent
A brain function improving agent using Bifidobacterium breve addresses cognitive decline and dementia symptoms by enhancing brain function and reducing cell death, providing a safer treatment option than current pharmaceuticals.
JP2026113699APending Publication Date: 2026-07-07MORINAGA MILK IND CO LTD
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- MORINAGA MILK IND CO LTD
- Filing Date
- 2026-04-13
- Publication Date
- 2026-07-07
AI Technical Summary
Technical Problem
As people age, brain functions such as learning ability and memory decline, leading to conditions like dementia, depression, and anxiety disorders, with Alzheimer's disease being a significant cause, and current treatments are inadequate.
Method used
A brain function improving agent containing Bifidobacterium breve and/or its culture is developed, which can prevent, treat, or improve symptoms of dementia, depression, and delirium, particularly targeting Alzheimer's disease, Lewy body dementia, and frontotemporal dementia.
Benefits of technology
The agent effectively enhances brain function by suppressing cell death and improving cognitive decline, offering a safe and effective alternative to existing treatments with minimal side effects.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure 2026113699000001 
Figure 2026113699000002 
Figure 2026113699000003
Abstract
To provide a new drug for improving brain function. [Solution] The present invention provides a brain function improving agent containing Bifidobacterium breve and / or a culture containing Bifidobacterium breve as an active ingredient.
Need to check novelty before this filing date? Find Prior Art